VAERS reports by lot

Merck HPV lot M032650: VAERS reports

35 VAERS reports list lot M032650 as a Merck HPV vaccine, received between 2016-11-22 and 2019-05-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
11%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1927%
General / Systemic (non-local)1115%
Injection-site / Local reaction1014%
Gastrointestinal811%
Cardiac / Cardiovascular710%
Dermatological (non-injection-site)68%
Allergic / Anaphylactic46%
Musculoskeletal23%
Psychiatric / Neuropsychiatric23%
Respiratory11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California8
New York3
Michigan3
Colorado3
Maryland2
Florida2
Indiana1
Hawaii1
Ohio1
Maine1
Kansas1
New Jersey1

Reports by month received

2016-114
2016-121
2017-013
2017-024
2017-031
2017-046
2017-053
2017-063
2017-073
2017-081
2017-091
2017-101
2017-121
2018-011
2018-021
2019-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.